TheraRadar
← Back
Data updated: Jun 28, 2026

VANTIVE US HLTHCARE

Big Pharma
Pharmaceuticals

VANTIVE US HLTHCARE is a major pharmaceutical company with 33 FDA-approved products.

1978
Since
33
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules

VANTIVE US HLTHCARE's Key Drugs

VANTIVE US HLTHCARE's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

VANTIVE US HLTHCARE's Recent FDA Approvals

New NDA/BLA approvals for VANTIVE US HLTHCARE over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

VANTIVE US HLTHCARE's Therapeutic Areas

Disease areas where VANTIVE US HLTHCARE has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

VANTIVE US HLTHCARE Pipeline Snapshot

Active clinical trials for VANTIVE US HLTHCARE across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling